ArticleEJHaem2024

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial.

Michael J R Desborough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.